ArticleFrontiers in immunology2025

The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study.

Bicheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.